Angie M.S. Tosson

Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects

Moushira Zaki, Hala T. El‐Bassyouni, Angie M.S. Tosson et al. · Jornal de Pediatria · 2016 · 36 citations · Full text

Evaluation of the S100 protein A12 as a biomarker of neonatal sepsis

Angie M.S. Tosson, Kirsten Glaser, Toni Weinhage et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2018 · 24 citations

Growth charts of Down syndrome in Egypt: A study of 434 children 0–36 months of age

Hanan H. Afifi, Mona Aglan, Moushira Zaki et al. · American Journal of Medical Genetics Part A · 2012 · 22 citations · Full text

Growth Charts, Motor Development, Anthropometric Indicator +17

Expanding the mutation and clinical spectrum of Roberts syndrome

Hanan H. Afifi, Ghada M. H. Abdel‐Salam, Maha M. Eid et al. · Congenital Anomalies · 2015 · 18 citations · Full text

Developmental Anomaly, Novel Esco2 Mutation, Mendelian Disorder +13

Evaluation of serum and salivary C-reactive protein for diagnosis of late-onset neonatal sepsis: A single center cross-sectional study

Angie M.S. Tosson, Dina M.T. Koptan, Rabab Abdel Aal et al. · Jornal de Pediatria · 2021 · 18 citations · Full text